E
BLFS icon

Ergoteles’s BioLife Solutions BLFS Stock Holding History

Ergoteles’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,338
Closed -$370K – 1280
2022
Q4 		$370K Buy
+20,338
New +$420K 0.01% 830
2022
Q1 		– Sell
-70,200
Closed -$2.62M – 1238
2021
Q4 		$2.62M Buy
+70,200
New +$3.01M 0.1% 212
2021
Q2 		– Sell
-8,000
Closed -$288K – 1498
2021
Q1 		$288K Buy
+8,000
New +$316K 0.01% 574

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ergoteles's BLFS Position: Q1 2023 in Review

Ergoteles sold out of BioLife Solutions (BLFS) in Q1 2023, closing a stake of 20,338 shares — an estimated $370K sold.

Ergoteles first reported a position in BLFS in Q1 2021 and held it in 3 quarters. The position peaked at $2.62M in Q4 2021. 169 funds tracked by Wall St. Rank hold BLFS as of Q1 2023.

  • Ergoteles reported no remaining BioLife Solutions position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 20,338 BioLife Solutions shares in Q1 2023, an estimated $370K.
  • Ergoteles first reported a position in BioLife Solutions in Q1 2021 and held it in 3 quarters.
  • Ergoteles's BioLife Solutions position peaked at $2.62M in Q4 2021.
  • 169 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.